Sort by
Refine Your Search
-
Department: Center for Molecular Neurology Regime Full-time Let’s shape the future - University of Antwerp The University of Antwerp is a dynamic, forward-thinking, European university. We offer
-
, molecular biology, or related disciplines FELASA certification Experience with or highly interested in experimental immunology (e.g. in vivo models, flow cytometry, imaging) Motivation to learn and apply
-
, neuroengineering and nanoscience, to single-cell, imaging and molecular analysis, functional genomics and cell biology in human and animal models. Doing a PhD at our Center Embedded within both VIB and KU Leuven, we
-
to build tomorrow's world every day. Through top scientific research, we push back boundaries and set a course for the future – a future that you can help to shape. The VIB-UAntwerp Center for Molecular
-
neurodevelopmental conditions, by bridging disciplines, from artificial intelligence, microelectronics, neuroengineering and nanoscience, to single-cell, imaging and molecular analysis, functional genomics and cell
-
Saelens team. Research Project In this research project you will develop probabilistic deep-learning models that automatically extract biological and statistical knowledge from in vivo perturbational omics
-
and Saeys teams. In this research project you will develop and apply algorithms to link clinical phenotypes of metastasis to molecular phenotypes in mouse models. It is known that metastases exhibit
-
-hydrated alkali-silicate melts that enable efficient zeolite formation under mild conditions. Molecular modeling and experimental characterization show that the type and concentration of the alkali cation
-
of a doctorate, contains: Are you eager to improve pandemic preparedness through data-driven research? Do you want to work on real-world implementation of AI and epidemiological models in healthcare
-
of the anti-MMP9 Nano-antibodies in a mouse model of delayed healing and a 3 weeks training at Nordic Bioscience( Herlev, Denmark) in the team of Dr. Signe Holm Nielsen to establish a Nano-antibodies based